Polyamyna Nanotech Inc. is an innovative biotechnology company based in St. John's, Newfoundland and Labrador, specializing in advanced antimicrobial technologies. Their product offerings include next-generation microbicidal coatings, antimicrobial fabrics, antifouling technologies, and point-of-care diagnostics aimed at combating antimicrobial resistance (AMR) and hospital-acquired infections (HAIs). With a focus on creating durable and effective solutions, Polyamyna aims to enhance infection prevention in healthcare settings and other environments, positioning itself as a leader in the fight against drug-resistant pathogens. Their commitment to innovation and sustainability is evident in their diverse technology pipeline, which includes both commercial-ready products and those in development, ensuring a robust market presence.
Something looks off?